Ten studies (1243 PD patients, 327 PSP patients) assessed the performance of NFL, Aβ42, t-α-syn, and p-tau in distinguishing between PD and PSP patients. The gene discussed is NEFL; the disease is supranuclear palsy, progressive, 1.